These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28562560)

  • 1. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
    Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
    Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.
    Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS
    Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease].
    Xiao J; Li Y; Fang M; Gong H; Li W; Zhang C; Chen F; Zhang Y; Han T
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1266-1271. PubMed ID: 39051072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
    Wang R; Dai L; Zhong Y; Xie G
    Lipids Health Dis; 2021 Jul; 20(1):77. PubMed ID: 34321005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
    BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Zhang F; Han Y; Wu Y; Bao Z; Zheng G; Liu J; Li W
    Ann Med; 2024 Dec; 56(1):2409342. PubMed ID: 39348274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between triglyceride glucose-body mass index and hypertension risk: evidence from a cross-sectional study with 60,283 adults in eastern China.
    Chen Y; Du J; Zhou N; Song Y; Wang W; Hong X
    BMC Cardiovasc Disord; 2024 May; 24(1):270. PubMed ID: 38783200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H; Han Y; Cao C; He Y
    J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.
    Zheng R; Du Z; Wang M; Mao Y; Mao W
    Lipids Health Dis; 2018 Nov; 17(1):262. PubMed ID: 30458848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients.
    Cai Y; Chen J; Deng X; Wang B; Huang J; Lian N
    BMC Pulm Med; 2024 Jul; 24(1):359. PubMed ID: 39049008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
    Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
    Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths.
    Song K; Park G; Lee HS; Lee M; Lee HI; Choi HS; Suh J; Kwon A; Kim HS; Chae HW
    J Pediatr; 2022 Mar; 242():79-85.e1. PubMed ID: 34808224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
    Kilonzo SB; Kamala E; Jaka H; Ngoya P
    BMC Gastroenterol; 2024 Mar; 24(1):96. PubMed ID: 38438930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children.
    Ye X; Li J; Wang H; Wu J
    Dis Markers; 2021; 2021():8833287. PubMed ID: 35059041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.